Literature DB >> 11052810

Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.

A Korte1, J Köchling, L Badiali, C Eckert, J Andreae, W Geilen, C Kebelmann-Betzing, T Taube, S Wu, G Henze, K Seeger.   

Abstract

In the family of cytokines and cytokine receptors, alternative splicing of pre-mRNA is a frequently observed process that generates different protein isoforms from a single genetic locus. The splicing-derived cytokine receptor protein isoforms are mostly soluble receptors or show alterations in their cytoplasmic domain. It is possible that receptor abnormalities or a pathological ratio of different isoforms may contribute to leukaemia by circumventing normal growth factor control or altering the balance of proliferation and differentiation. IL-7 plays a critical role in early stages of both B and T cell maturation. Moreover, it stimulates the expansion of mature T cells including anti-tumour reactive cells as well as a number of T and B cell malignancies underlining its potential importance for deregulated lymphoid proliferation and leukaemogenesis. Here, we present detailed data on the expression of the interleukin 7 receptor alpha chain (IL-7Ralpha) in leukaemic cells from 210 children with acute lymphoblastic leukaemia (ALL) and describe two novel alternatively spliced transcripts of human IL-7Ralpha coding for truncated receptor proteins which are still capable of binding IL-7. IL-7Ralpha mRNA expression was more frequent in more mature pre-B ALL [91% (30/33)] than in common [81% (81/100)] or pro-B ALL [64% (18/28)], or even in T ALL [64% (29/45)]. These results are in concordance with flow cytometric analyses on the proportion of IL-7Ralpha bearing cells among total blast cell population. Our results lead us to assume that splicing derived IL-7Ralpha isoforms play a potential role in modulating IL-7 signal transduction and might be important for the pathogenesis of leukaemia. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052810     DOI: 10.1006/cyto.2000.0777

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

Review 1.  Alternative splicing in multiple sclerosis and other autoimmune diseases.

Authors:  Irina Evsyukova; Jason A Somarelli; Simon G Gregory; Mariano A Garcia-Blanco
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

2.  Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.

Authors:  D R Booth; A T Arthur; S M Teutsch; C Bye; J Rubio; P J Armati; J D Pollard; R N S Heard; G J Stewart
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

3.  Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.

Authors:  Irina Evsyukova; Shelton S Bradrick; Simon G Gregory; Mariano A Garcia-Blanco
Journal:  RNA       Date:  2012-11-14       Impact factor: 4.942

4.  Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients.

Authors:  Julie Demaret; Astrid Villars-Méchin; Alain Lepape; Jonathan Plassais; Hélène Vallin; Christophe Malcus; Françoise Poitevin-Later; Guillaume Monneret; Fabienne Venet
Journal:  Intensive Care Med       Date:  2014-06-25       Impact factor: 17.440

5.  Transcriptional regulation of the IL-7Rα gene by dexamethasone and IL-7 in primary human CD8 T cells.

Authors:  Juzer A Kakal; Feras M Ghazawi; Elliott M Faller; Scott M Sugden; Parmvir Parmar; Paul A MacPherson
Journal:  Immunogenetics       Date:  2016-08-19       Impact factor: 2.846

6.  Polymorphism in the interleukin-7 receptor-alpha and outcome after allogeneic hematopoietic cell transplantation with matched unrelated donor.

Authors:  Z Shamim; S Spellman; M Haagenson; T Wang; S J Lee; L P Ryder; K Müller
Journal:  Scand J Immunol       Date:  2013-08       Impact factor: 3.487

7.  Interleukin (IL)-7 Signaling in the Tumor Microenvironment.

Authors:  Iwona Bednarz-Misa; Mariusz A Bromke; Małgorzata Krzystek-Korpacka
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Increased soluble IL-7 receptor concentrations associate with improved IL-7 therapy outcomes in SIV-infected ART-treated Rhesus macaques.

Authors:  Amanda K Steele; Lorna Carrasco-Medina; Donald L Sodora; Angela M Crawley
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

Review 9.  Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent.

Authors:  Priscila O Barros; Tamara K Berthoud; Nawaf Aloufi; Jonathan B Angel
Journal:  Immunotargets Ther       Date:  2021-03-08

10.  Development of a quantitative bead capture assay for soluble IL-7 receptor alpha in human plasma.

Authors:  Sylvie Faucher; Angela M Crawley; Wendy Decker; Alice Sherring; Dragica Bogdanovic; Tao Ding; Michele Bergeron; Jonathan B Angel; Paul Sandstrom
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.